ClinicalTrials.Veeva

Menu

Use of Low-level Laser Therapy (808nm) to Muscle Fatigue Resistance

C

Cleber Ferraresi

Status

Completed

Conditions

Healthy

Treatments

Device: Placebo low-level laser therapy
Other: isokinetic exercise
Device: Low-level laser therapy (808nm)

Study type

Interventional

Funder types

Other

Identifiers

NCT01972100
CEP/UFRN 401/09

Details and patient eligibility

About

The study hypothesis is a improved muscle fatigue resistance induced by low-level laser therapy applied between sets of intense exercises.

Enrollment

7 patients

Sex

Male

Ages

18 to 28 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • healthy males
  • physically active
  • aged between 18-28 years old

Exclusion criteria

  • smoker
  • under medicine
  • lower limb lesions limiting the flexion-extension of the knee joint

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

7 participants in 2 patient groups

Low-level laser therapy (LLLT)
Active Comparator group
Description:
Use of low-level laser therapy (LLLT) to induce a muscle fatigue resistance in intense exercises
Treatment:
Device: Low-level laser therapy (808nm)
Other: isokinetic exercise
Placebo low-level laser therapy (Placebo)
Active Comparator group
Description:
Use of low-level laser therapy (LLLT) placebo to induce a muscle fatigue resistance
Treatment:
Device: Placebo low-level laser therapy
Other: isokinetic exercise

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems